Related Experiment Video
Updated: Nov 10, 2025
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
Published on: April 10, 2020
The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics
John T Gamble1, Daniel J Elson2, Juliet A Greenwood3
1Department of Biochemistry & Biophysics, Oregon State University, Corvallis, OR 97331, USA.
Abstract:
In order to develop new cancer therapeutics, rapid, reliable, and relevant biological models are required to screen and validate drug candidates for both efficacy and safety. In recent years, the zebrafish (Danio rerio) has emerged as an excellent model organism suited for these goals. Larval fish or immunocompromised adult fish are used to engraft human cancer cells and serve as a platform for screening potential drug candidates. With zebrafish sharing ~80% of disease-related orthologous genes with humans, they provide a low cost, high-throughput alternative to mouse xenografts that is relevant to human biology. In this review, we provide background on the methods and utility of zebrafish xenograft models in cancer research.
Insights
Zebrafish xenografts offer a rapid, cost-effective model for cancer drug discovery. These models utilize zebrafish to screen drug candidates, providing a relevant alternative to traditional mouse studies.
Area of Science:
- Comparative genomics
- Cancer biology
- Drug discovery
Background:
- Developing novel cancer therapeutics requires efficient screening models.
- Zebrafish (Danio rerio) are increasingly used as a biological model for cancer research.
- Existing models like mouse xenografts have limitations in cost and throughput.
Purpose of the Study:
- To review the methods and utility of zebrafish xenograft models in cancer research.
- To highlight zebrafish as a relevant and high-throughput model for drug screening.
- To provide background on the application of zebrafish in preclinical cancer studies.
Main Methods:
- Engrafting human cancer cells into larval or immunocompromised adult zebrafish.
- Utilizing zebrafish as a living platform for drug candidate screening.
- Comparing zebrafish models to traditional mouse xenografts for cancer research.
Main Results:
- Zebrafish share approximately 80% of human disease-related orthologous genes.
- Zebrafish xenografts provide a low-cost, high-throughput screening alternative.
- These models are relevant to human biology for efficacy and safety validation.
Conclusions:
- Zebrafish xenograft models are a valuable tool for developing new cancer therapeutics.
- Their genetic similarity to humans and cost-effectiveness make them ideal for drug screening.
- Further adoption of zebrafish models can accelerate cancer drug discovery and validation.
